5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Amrutanjan Health Care Ltd.

•
amrutanjan.comBSE: 590006NSE: AMRUTANJAN
Market Cap₹ 1,418 Cr.
Current Price
High / Low₹ 774 / 483
Stock P/E26.3
Book Value₹ 130
Price to Book3.86
Dividend Yield1.00 %
ROCE22.5 %
ROE16.6 %
Face Value₹ 1

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2026 • OTC Products: 65.3% • Women Hygiene: 27.8% • Beverages: 6.3%

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Company is almost debt free
  • Company has a healthy return on capital (ROCE) of 22.2%
  • Working capital cycle has improved - days down from 166 to 120
  • Stock looks reasonably valued - P/E of 26.3 is below its historical median
  • Company has a consistent dividend-paying track record
  • Company generates healthy free cash flow

CONS

  • Promoter holding has decreased over last 2 years: -4.1pp
  • Company has delivered a poor profit growth of -1.1% over past five years

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs
Part ofNIFTY 50NIFTY 500NIFTY LARGEMIDCAP 250NIFTY 100NIFTY 200
S.No.Name
1.SUNPHARMA1842.0036.54441957.500.872901.2326.5315299.8810.9819.1128.81
2.DIVISLAB9326.0084.64247576.000.32902.0065.503080.0027.8021.5140.75
3.TORNTPHARM4975.0086.76189233.010.76566.003.284921.0057.3219.2733.81
4.ZYDUSLIFE1119.5024.74111670.550.09990.20-34.908017.0023.9721.3924.54
5.CIPLA1365.0032.72110272.680.95785.55-39.187119.284.1316.0016.73
6.LAURUSLABS1970.3597.37106460.420.10362.07123.942026.3129.1018.2031.50
7.DRREDDY1161.0030.0796906.380.69435.60-69.108099.80-5.2113.7510.63
8.AUROPHARMA1675.4525.9796401.690.241032.0325.229150.3517.4412.7620.54
9.LUPIN2096.0017.3495842.920.861416.9816.018276.8934.2828.8629.59
10.MANKIND2277.0046.0494050.370.04574.0929.124030.5912.8913.2426.30
11.GLENMARK2416.9037.9468210.880.10482.83927.884018.4831.3520.3520.03
12.AMRUTANJAN490.3567.051417.631.004.37-47.46102.979.4822.466.06
Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
78991171278411012313594118141150103
7192951118096991188610111612499
Operating Profit772216414231881725264
OPM %9.18%6.89%18.44%12.77%4.24%12.38%19.02%13.07%8.98%14.04%17.85%17.05%4.16%
44454445443-36
Interest0000000000000
Depreciation1222222222222
Profit before Tax9924206162621111926216
Tax %25.66%25.62%26.40%30.34%27.24%26.04%25.93%27.23%26.40%27.33%26.21%22.93%28.08%
Net Profit771714512191581419164
2.402.366.054.721.604.086.665.252.874.836.735.601.51

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
212220253261333406380421452503511
182192222231266328335369394427440
Operating Profit3028313167784552587672
OPM %14.06%12.86%12.21%11.79%20.20%19.11%11.73%12.32%12.91%15.09%13.98%
78781917151618910
Interest10001100000
Depreciation33344456767
Profit before Tax3433353482915462697873
Tax %35.19%39.16%29.32%27.20%25.29%25.82%25.74%27.40%26.47%25.64%25.71%
Net Profit2220252561674045515854
EPS0.0013.670.008.5820.9322.9813.6315.5617.5820.03—
Dividend Payout %25.81%28.43%25.64%24.47%20.06%20.01%33.76%29.57%26.16%24.46%—

COMPOUNDED SALES GROWTH

10 Years:
11%
5 Years:
9%
3 Years:
10%

COMPOUNDED PROFIT GROWTH

10 Years:
10%
5 Years:
-1%
3 Years:
13%

STOCK PRICE CAGR

10 Years:
9%
5 Years:
-7%
3 Years:
-8%
1 Year:
-35%

RETURN ON EQUITY

10 Years:
19%
5 Years:
18%
3 Years:
16%
Last Year:
17%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Corporate actions

2026

Sep 11

₹ 2.90

Rs.2.9000 per share(290%)Final Dividend

2026

Feb 6

₹ 1

Rs.1.0000 per share(100%)Interim Dividend

2025

Nov 18

₹ 1

Rs.1.0000 per share(100%)Interim Dividend

2025

Sep 16

₹ 2.60

Rs.2.6000 per share(260%)Final Dividend

2025

Feb 18

₹ 1

Rs.1.0000 per share(100%)Interim Dividend

2024

Nov 22

₹ 1

Interim Dividend

2024

Sep 13

₹ 2.60

Rs.2.6000 per share(260%)Final Dividend

2024

Feb 20

₹ 1

Second Interim Dividend

2023

Nov 23

₹ 1

Rs.1.0000 per share(100%)Interim Dividend

2023

Sep 14

₹ 2.60

Rs.2.6000 per share(260%)Final Dividend

2023

Feb 24

₹ 1

Interim Dividend

2022

Nov 14

₹ 1

First Interim Dividend

2022

Sep 14

₹ 2.60

Rs.2.6000 per share(260%)Final Dividend

2022

Feb 18

₹ 1

Second Interim Dividend

2021

Nov 16

₹ 1

First Interim Dividend

2021

Sep 15

₹ 2.60

Rs.2.6000 per share(260%)Final Dividend

2021

Feb 17

₹ 0.80

Second Interim Dividend

2020

Nov 19

₹ 0.80

First Interim Dividend

2020

Feb 18

₹ 1.55

Second Interim Dividend

2018

Sep 7

₹ 0.85

Rs.0.8500 per share(85%)Final Dividend

2018

Feb 22

₹ 0.55

Rs.1.10(55%) 2nd Interim Dividend

2017

Nov 16

₹ 0.55

First Interim Dividend

2017

Sep 13

Rs.1.6500 per share(82.5%)Final Dividend

2017

Feb 16

₹ 0.55

Interim Dividend

2016

Nov 17

₹ 0.55

First Interim Dividend

2016

Mar 18

Second Interim Dividend

2016

Feb 17

₹ 0.60

Interim Dividend

2015

Sep 10

₹ 1.20

Rs.2.4000 per share(120%)Final Dividend

2019

Feb 7

Second Interim Dividend

2026

Aug 13

₹ 2.90

Rs.2.9000 per share(290%)Final Dividend

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital3333333333
113126143157212262287286323368
3001101222
Trade Payables25263031416047566971
5779142120172159
Total Liabilities149162183201271346358364418504
27282626232849504951
Capital Work in Progress10000161216105
108181818135003
10101524172629292737
00026000485661
Cash & Bank317381361398870278333
7144447073175203208186212
Total Assets149162183201271346358364418504

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
223031181107636285136
Cash from Investing-0-8-11-14-88-36-219-31-21
Cash from Financing-5-9-7-12-7-17-15-48-13-14
323-7-4-13-161

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
50.5946.5246.5246.5246.5246.5246.5246.5246.52
1.552.342.302.302.412.382.272.172.44
7.3210.6011.1311.4112.7012.9013.0012.6612.29
Government0.000.000.000.000.000.000.000.000.00
40.5440.5440.0639.7738.3738.2038.2238.6538.76

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-08-28
Updates

2026-08-28 - Amrutanjan Health Care Limited has informed the Exchange regarding 'BRSR for the FY 2025-26'.

2026-08-28
Shareholders meeting

2026-08-28 - Amrutanjan Health Care Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 23, 2026

2026-08-12
Investor Presentation

2026-08-12 - Amrutanjan Health Care Limited has informed the Exchange about Investor Presentation

2026-08-11
Record Date

2026-08-11 - Amrutanjan Health Care Limited has informed the Exchange that Record date for the purpose of Dividend & Meeting is 11-Sep-2026.

2026-08-11
Outcome of Board Meeting

2026-08-11 - Amrutanjan Health Care Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

2026-08-05
Commencement of commercial production/operations

2026-08-05 - Amrutanjan Health Care Limited has informed the Exchange about Commencement of commercial production/operations

2026-08-05
Credit Rating

2026-08-05 - Amrutanjan Health Care Limited has informed the Exchange about Credit Rating

2026-08-01
Action(s) taken or orders passed

2026-08-01 - Amrutanjan Health Care Limited has informed the Exchange about Action(s) taken or orders passed

2026-07-08
Certificate under SEBI (Depositories and Participants) Regulations, 2018

2026-07-08 - Amrutanjan Health Care Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

News

Recent coverage and analyst commentary for AMRUTANJAN

Loading news…

🤖

AI Stock Analyst

Amrutanjan Health Care Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login